Tamir Biotechnology, Inc. (formerly Alfacell Corporation) targeting microRNAs, is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials.
Beskrivning av företaget:
the product candidate, onconase®, is an rnase that overcomes the challenges of targeting rna for therapeutic purposes while enabling the development of a new class of therapies for cancer, viral, and other life-threatening diseases.
kopiera och klistra in den här google map på din webbplats eller blogg!
Tryck på Kopiera knappen och klistra in i din blogg eller hemsida.
(Gå över till " HTML "-läge när du postar in i din blogg. Examples: WordPress Example, Blogger Example)